Pliant Therapeutics Prices IPO At $16/shr, High End Of Its Expected Range

Pliant Therapeutics, Inc. announced the pricing of initial public offering of 9 million common shares at $16.00 per share. The company shares are expected to begin trading on Nasdaq Global Select Market on June 3, 2020 under the ticker symbol "PLRX."